每年專案
個人檔案
學歷
- 2012 國立成功大學基礎醫學研究所博士
- 2007 國立成功大學生理學研究所碩士
- 2004 中臺科技大學醫學影像暨放射科學系學士
經歷
- 2022- 臺北醫學大學神經再生醫學博士學位學程副教授
- 2019-2022 臺北醫學大學神經再生醫學博士學位學程助理教授
- 2018-2019 臺北醫學大學神經醫學研究中心助理研究員
- 2017-2019 臺北醫學大學神經再生醫學博士學位學程助理研究員
- 2016-2018 臺北醫學大學神經損傷及再生研究中心助理研究員
- 2012-2015 國立成功大學傳染性疾病與訊息研究中心博士後研究員
獎項
- 2014科技部103年度博士後研究優秀論文獎
- 2012 成功大學醫學院博士班優秀論文獎
研究興趣
- 腫瘤生物學
- 癌症小鼠模式
相關連結
指紋
查看啟用 Tsung-I Hsu 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
- 1 類似的個人檔案
過去五年中的合作和熱門研究領域
國家/地區層面的近期外部共同作業。按一下圓點深入探索詳細資料，或
-
針對膠質母細胞瘤的治療抵抗力：黃體酮透過調節蛋白質唾液酸化增強化療和免疫治療反應的作用(1/3)
Hsu, T.-I. (PI)
8/1/24 → 7/31/25
研究計畫: A - 政府部門 › b - 國家科學及技術委員會
-
透過調整腫瘤細胞中的類固醇合成至别孕烷醇酮和重新編程脂肪酸代謝來促進自然殺手細胞治療膠質母細胞瘤
Hsu, T.-I. (PI)
8/1/23 → 7/31/24
研究計畫: A - 政府部門 › b - 國家科學及技術委員會
-
-
-
-
Potential role of solid lipid curcumin particle (SLCP) as estrogen replacement therapy in mitigating TDP-43-related neuropathy in the mouse model of ALS disease
Majumder, P., Hsu, T. I., Hu, C. J., Huang, J. K., Lee, Y. C., Hsieh, Y. C., Ahsan, A. & Huang, C. C., 1月 2025, 於: Experimental Neurology. 383, 114999.研究成果: 雜誌貢獻 › 文章 › 同行評審
開啟存取 -
Repurposing Linezolid in Conjunction with Histone Deacetylase Inhibitor Access in the Realm of Glioblastoma Therapies
Chen, I. C., Lin, H. Y., Liu, Z. Y., Cheng, W. J., Yeh, T. Y., Yang, W. B., Tran, H. Y., Lai, M. J., Wang, C. H., Kao, T. Y., Hung, C. Y., Huang, Y. L., Liou, K. C., Hsieh, C. M., Hsu, T. I. & Liou, J. P., 2025, 於: Journal of Medicinal Chemistry. 68, 3, p. 2779-2803 25 p.研究成果: 雜誌貢獻 › 文章 › 同行評審
開啟存取 -
Dual inhibition of CYP17A1 and HDAC6 by abiraterone-installed hydroxamic acid overcomes temozolomide resistance in glioblastoma through inducing DNA damage and oxidative stress
Sharma, R., Chiang, Y. H., Chen, H. C., Lin, H. Y., Yang, W. B., Nepali, K., Lai, M. J., Chen, K. Y., Liou, J. P. & Hsu, T. I., 4月 1 2024, 於: Cancer Letters. 586, 216666.研究成果: 雜誌貢獻 › 文章 › 同行評審
6 引文 斯高帕斯（Scopus） -
Exploring neuron-specific steroid synthesis and DHEAS therapy in Alzheimer's disease
Lin, H. Y., Feng, Y. H., Kao, T. J., Chen, H. C., Chen, G. Y., Ko, C. Y. & Hsu, T. I., 10月 2024, 於: Journal of Steroid Biochemistry and Molecular Biology. 243, 106585.研究成果: 雜誌貢獻 › 文章 › 同行評審
1 引文 斯高帕斯（Scopus） -
First-in-Class Dual EZH2-HSP90 Inhibitor Eliciting Striking Antiglioblastoma Activity In Vitro and In Vivo
Sharma, S., Wang, S. A., Yang, W. B., Lin, H. Y., Lai, M. J., Chen, H. C., Kao, T. Y., Hsu, F. L., Nepali, K., Hsu, T. I. & Liou, J. P., 2月 22 2024, 於: Journal of Medicinal Chemistry. 67, 4, p. 2963-2985 23 p.研究成果: 雜誌貢獻 › 文章 › 同行評審
開啟存取4 引文 斯高帕斯（Scopus）
資料集
-
MOESM6 of Enrichment of superoxide dismutase 2 in glioblastoma confers to acquisition of temozolomide resistance that is associated with tumor-initiating cell subsets
Chuang, J.-Y. (Creator), Chen, S.-H. (Contributor), Yang, K.-Y. (Creator), Chien, C.-H. (Contributor), Liu, J.-J. (Creator), Hsu, T.-I. (Contributor), Chang, K.-Y. (Contributor), Yang, S.-T. (Creator), Chu, J.-M. (Contributor), Chou, S.-W. (Creator), Lo, W.-L. (Creator), Liu, M.-S. (Creator), Huang, C.-Y. (Contributor), Yang, W.-B. (Creator), Chen, P.-Y. (Contributor) & Chung, P.-H. (Contributor), Figshare, 2019
DOI: 10.6084/m9.figshare.10006874.v1, https://doi.org/10.6084%2Fm9.figshare.10006874.v1
資料集: Dataset
-
MOESM3 of Enrichment of superoxide dismutase 2 in glioblastoma confers to acquisition of temozolomide resistance that is associated with tumor-initiating cell subsets
Liu, J.-J. (Creator), Hsu, T.-I. (Contributor), Chou, S.-W. (Creator), Chuang, J.-Y. (Creator), Yang, W.-B. (Creator), Chen, P.-Y. (Contributor), Chen, S.-H. (Contributor), Yang, S.-T. (Creator), Chu, J.-M. (Contributor), Huang, C.-Y. (Contributor), Yang, K.-Y. (Creator), Chien, C.-H. (Contributor), Chung, P.-H. (Contributor), Lo, W.-L. (Creator), Liu, M.-S. (Creator) & Chang, K.-Y. (Contributor), Figshare, 2019
DOI: 10.6084/m9.figshare.10006856.v1, https://doi.org/10.6084%2Fm9.figshare.10006856.v1
資料集: Dataset
-
MOESM7 of Enrichment of superoxide dismutase 2 in glioblastoma confers to acquisition of temozolomide resistance that is associated with tumor-initiating cell subsets
Chou, S.-W. (Creator), Chen, P.-Y. (Contributor), Chu, J.-M. (Contributor), Chien, C.-H. (Contributor), Liu, J.-J. (Creator), Liu, M.-S. (Creator), Chuang, J.-Y. (Creator), Chung, P.-H. (Contributor), Hsu, T.-I. (Contributor), Chen, S.-H. (Contributor), Yang, S.-T. (Creator), Lo, W.-L. (Creator), Huang, C.-Y. (Contributor), Chang, K.-Y. (Contributor), Yang, K.-Y. (Creator) & Yang, W.-B. (Creator), Figshare, 2019
DOI: 10.6084/m9.figshare.10006880.v1, https://doi.org/10.6084%2Fm9.figshare.10006880.v1
資料集: Dataset
-
MOESM2 of Enrichment of superoxide dismutase 2 in glioblastoma confers to acquisition of temozolomide resistance that is associated with tumor-initiating cell subsets
Chen, P.-Y. (Contributor), Yang, W.-B. (Creator), Chou, S.-W. (Creator), Yang, S.-T. (Creator), Chung, P.-H. (Contributor), Chang, K.-Y. (Contributor), Liu, M.-S. (Creator), Chen, S.-H. (Contributor), Chien, C.-H. (Contributor), Hsu, T.-I. (Contributor), Chu, J.-M. (Contributor), Huang, C.-Y. (Contributor), Yang, K.-Y. (Creator), Liu, J.-J. (Creator), Chuang, J.-Y. (Creator) & Lo, W.-L. (Creator), Figshare, 2019
DOI: 10.6084/m9.figshare.10006850.v1, https://doi.org/10.6084%2Fm9.figshare.10006850.v1
資料集: Dataset
-
MOESM8 of Enrichment of superoxide dismutase 2 in glioblastoma confers to acquisition of temozolomide resistance that is associated with tumor-initiating cell subsets
Chung, P.-H. (Contributor), Chen, S.-H. (Contributor), Hsu, T.-I. (Contributor), Liu, M.-S. (Creator), Lo, W.-L. (Creator), Chu, J.-M. (Contributor), Yang, K.-Y. (Creator), Yang, S.-T. (Creator), Liu, J.-J. (Creator), Chuang, J.-Y. (Creator), Yang, W.-B. (Creator), Huang, C.-Y. (Contributor), Chien, C.-H. (Contributor), Chang, K.-Y. (Contributor), Chen, P.-Y. (Contributor) & Chou, S.-W. (Creator), Figshare, 2019
DOI: 10.6084/m9.figshare.10006883.v1, https://doi.org/10.6084%2Fm9.figshare.10006883.v1
資料集: Dataset